271 related articles for article (PubMed ID: 27356721)
1. Reduced Ovarian Cancer Incidence in Women Exposed to Low Dose Ionizing Background Radiation or Radiation to the Ovaries after Treatment for Breast Cancer or Rectosigmoid Cancer.
Lehrer S; Green S; Rosenzweig KE
Asian Pac J Cancer Prev; 2016; 17(6):2979-82. PubMed ID: 27356721
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer hormesis in high impact states where nuclear testing occurred.
Lehrer S; Rosenzweig KE
Clin Lung Cancer; 2015 Mar; 16(2):152-5. PubMed ID: 25458560
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer.
Liang JT; Lai HS; Wu CT; Huang KC; Lee PH; Shun CT
Ann Surg Oncol; 2007 Jul; 14(7):1991-9. PubMed ID: 17447107
[TBL] [Abstract][Full Text] [Related]
5. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care of radiation therapy in patients with stage IV rectal cancer: a Surveillance, Epidemiology, and End Results analysis of patients from 2004 to 2009.
Logan JK; Huber KE; Dipetrillo TA; Wazer DE; Leonard KL
Cancer; 2014 Mar; 120(5):731-7. PubMed ID: 24227451
[TBL] [Abstract][Full Text] [Related]
7. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
8. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
9. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
10. [Ileal obstruction following radiosurgical treatment for rectosigmoid neoplasm].
Cerrotta A; Gardani G; Lozza L; Kenda R; Tana S; Valvo F; Zucali R
Radiol Med; 1995 May; 89(5):643-6. PubMed ID: 7617904
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and treatment of patients receiving radiation for cancer of the rectum or sigmoid colon in the United States: results of the 1988-1989 Patterns of Care Study process survey.
Coia L; Wizenberg M; Hanlon A; Gunderson L; Haller D; Hoffman J; Kline R; Mohiuddin M; Russell A; Tepper J
J Clin Oncol; 1994 May; 12(5):954-9. PubMed ID: 8164047
[TBL] [Abstract][Full Text] [Related]
12. Young premenopausal women with breast cancer, especially estrogen receptor negative, are at significantly increased risk for subsequent ovarian cancer.
Lehrer S; Rheinstein PH; Green S; Rosenzweig KE
Discov Med; 2016 Oct; 22(121):209-213. PubMed ID: 27875672
[TBL] [Abstract][Full Text] [Related]
13. The effect of primary tumor radiotherapy in patients with Unresectable stage IV Rectal or Rectosigmoid Cancer: a propensity score matching analysis for survival.
Wang G; Wang W; Jin H; Dong H; Chen W; Li X; Li G; Li L
Radiat Oncol; 2020 May; 15(1):126. PubMed ID: 32460810
[TBL] [Abstract][Full Text] [Related]
14. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA
Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
[TBL] [Abstract][Full Text] [Related]
16. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
Hoffman KE; Hong TS; Zietman AL; Russell AH
Cancer; 2008 Feb; 112(4):943-9. PubMed ID: 18098220
[TBL] [Abstract][Full Text] [Related]
17. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
18. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
Modrek AS; Hsu HC; Leichman CG; Du KL
Radiat Oncol; 2015 Apr; 10():101. PubMed ID: 25902707
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists.
Bhatti P; Struewing JP; Alexander BH; Hauptmann M; Bowen L; Mateus-Pereira LH; Pineda MA; Simon SL; Weinstock RM; Rosenstein M; Stovall M; Preston DL; Linet MS; Doody MM; Sigurdson AJ
Int J Cancer; 2008 Jan; 122(1):177-82. PubMed ID: 17764108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
